UCB signs Eu1.5bn after pulling bridge bond
Belgian pharmaceutical group UCB signed a Eu1.5bn loan this week in its latest move to refinance acquisition debt. However, a planned Eu500m tranche was missing after the company instead found demand in the bond market earlier in December.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ European securitization issuance database
- ✔ Daily newsletters across markets and asset classes
- ✔ 1 weekly securitization podcast
